Novelion Therapeutics
Biotechnology Research · 201 Employees
- Overview
- Employees
Access 6 Verified Employees Profiles for Novelion TherapeuticsUnlock Free Contacts Now
About
Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.
Website
Year Founded
1981
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Boston, US
Keywords
--
Location
- Boston, US
Email Formats
Sign up for free credits and discover verified email addresses of Novelion Therapeutics
FormatExamples
first + last
andywarhol@novelion.com
first_initial + last
awarhol@novelion.com
first + last_initial
andyw@novelion.com
first
andy@novelion.com
last
warhol@novelion.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Novelion Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.